November 7, 2012
  • Are New Drugs Viable Solution to Warfarin
    Treatment Nonadherence?

    Oral anticoagulation therapy can decrease the incidence of cardioembolic stroke in patients with atrial fibrillation by half or more, but many patients fail to continue with it over the long term. In fact, a new Canadian study found that, within 5 years, 61% of older patients had discontinued their warfarin treatment. Why is that occurring and what are some possible solutions?  

  • Substantially Fewer Americans Need Vitamin D Supplement With New Guidelines

    For pharmacists asked by customers if vitamin D supplementation is necessary for them, the answer probably is “no.” Based on Institute of Medicine guidelines issued last year, more than 80 million Americans previously considered as having too low levels of vitamin D no longer require supplementation, according to a new study. Here is what else the study says about the guidelines and their significant effect.  

  • FDA: Pharmacists Should Warn Customers About Dangers of Some OTC Drops, Sprays

    Some OTC eye drops and nasal sprays can be dangerous for small children, and pharmacists are being asked to caution parents and caregivers about them. The FDA reports that products containing tetrahydrozoline, oxymetazoline, or naphazoline have caused serious reactions when ingested by children 5 years old and younger. Here is what pharmacists need to tell customers about them.

  • SSRI Use by Pregnant Woman May Be Too Risky,
    Study Warns

    Women seeking to become pregnant while taking selective serotonin reuptake inhibitors (SSRIs) for depression need to be warned about the substantial risks, according to a new study. The study suggests, in fact, that the drugs fail to lead to better outcomes for mothers or babies while increasing the risks of everything from miscarriage to neonatal health complications. Here is what they recommend instead.

U.S. Pharmacist Social Connect